Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPhoenix Group Holdings Regulatory News (PHNX)

  • There is currently no data for PHNX

Board Changes

25 Aug 2016 07:00

RNS Number : 0802I
Phoenix Group Holdings
25 August 2016
 

 

Phoenix Group Holdings - Board Changes

 

The Board of Phoenix Group Holdings ("Phoenix") is pleased to announce the appointments of three new non-executive directors, Wendy Mayall, John Pollock and Nicholas Shott, all with effect from 1 September 2016.

 

Wendy Mayall has over thirty years' asset management experience, including as Group Chief Investment Officer and latterly consultant at Liverpool Victoria from 2012 to 2015, having previously been Chief Investment Officer for Unilever's UK pension fund from 1996 to 2011 and holding management responsibility for Unilever's pension funds globally. From 2006 to 2009, she was the Chair of the Investment Committee of the Mineworkers Pension Scheme, a British government appointment to one of the largest government backed pension schemes in the UK. Mrs Mayall is the non-executive Senior Independent Director of the Aberdeen UK Tracker Trust plc.

 

John Pollock had a highly successful career in life assurance at the Legal & General Group from 1980 to 2015, including as an executive director of Legal & General Group plc from 2003 to 2015. He held numerous senior roles, gaining wide strategic and technical experience, finally as Chief Executive Officer of LGAS (L&G Assurance Society), one of Legal and Generals' three primary business units, employing 6,000 staff. His previous roles included Chief Executive Officer (Protection and Annuities). Prior to his retirement from Legal and General in 2015, Mr Pollock held positions as Deputy Chair of the FCA Practitioner Panel, Chairman of investment platform Cofunds, and as a non-executive director of the Cala Homes Group.

 

Nicholas Shott is a highly experienced investment banker, who is European Vice Chairman of Lazard, a role he has held since 2007, and Head of UK Investment Banking at Lazard, which he has been since 2009. He joined Lazard in 1991 and became a partner in 1997. His wide experience of successfully advising clients on M&A deals in various sectors over many years is expected to be of significant benefit to Phoenix in pursuing its acquisition strategy.

 

The Phoenix Board also announces that Rene-Pierre Azria will be leaving the Board on 30 November 2016 after seven years as a non-executive director.

 

Commenting on the Board changes, Henry Staunton, Phoenix Chairman said: "I am delighted that we have secured the appointments to the Phoenix Board of three such experienced and successful individuals who will enhance the Board skillset in both quality and diversity. I would like to thank Rene-Pierre Azria for his valuable contribution to Phoenix since his appointment to the Board in September 2009 and through its progress as a premium listed company from July 2010. On behalf of all the Board, I wish him well."

 

No other information is required to be notified under Listing Rule 9.6.13 R.

 

Enquiries:

MediaNeil Bennett, MaitlandPeter Ogden, Maitland+ 44 (0) 20 7379 5151

InvestorsSam Perowne, Head of Investor Relations, Phoenix Group+44 (0) 203 735 0021

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAPIMLTMBITBBF
Date   Source Headline
7th Mar 20174:30 pmRNSDirector/PDMR Shareholding
28th Feb 20174:00 pmRNSTotal Voting Rights
16th Feb 20174:30 pmRNSDirector/PDMR Shareholding
8th Feb 20174:30 pmRNSDirector/PDMR Shareholding
10th Jan 20173:30 pmRNSDirector/PDMR Shareholding
10th Jan 20177:00 amRNSTrading Update and Credit Investor Roadshow
5th Jan 20174:30 pmRNSDirector/PDMR Shareholding
30th Dec 201610:42 amRNSCompletion of the Abbey Life Acquisition
28th Dec 20164:00 pmRNSDirector/PDMR Shareholding
20th Dec 201612:30 pmRNSHolding(s) in Company
14th Dec 20165:15 pmRNSHolding(s) in Company
13th Dec 20164:30 pmRNSHolding(s) in Company
13th Dec 20163:00 pmRNSRegulatory Consent - Abbey Life Acquisition
7th Dec 20163:30 pmRNSDirector/PDMR Shareholding
2nd Dec 20164:30 pmRNSDirector/PDMR Shareholding
30th Nov 20164:00 pmRNSTotal Voting Rights
30th Nov 20162:45 pmRNSDirectorate Change
24th Nov 20164:30 pmRNSDirector/PDMR Shareholding
23rd Nov 20164:45 pmRNSDirector/PDMR Shareholding
21st Nov 20165:00 pmRNSDirector/PDMR Shareholding
17th Nov 20166:15 pmRNSDirector/PDMR Shareholding
17th Nov 20166:15 pmRNSDirector/PDMR Shareholding
17th Nov 20166:15 pmRNSDirector/PDMR Shareholding
15th Nov 201610:00 amRNSHolding(s) in Company
11th Nov 20166:00 pmRNSDirector/PDMR Shareholding
11th Nov 201611:00 amRNSHolding(s) in Company
9th Nov 20165:13 pmRNSDirector/PDMR Shareholding
9th Nov 201612:00 pmRNSTotal Voting Rights
9th Nov 201611:30 amRNSResults of Rump Placing
9th Nov 20167:00 amRNSResults of Rights Issue
3rd Nov 20164:00 pmRNSDirector/PDMR Shareholding
1st Nov 20164:30 pmRNSDirector/PDMR Shareholding
1st Nov 20167:45 amRNSCompletion of the AXA Business Acquisition
31st Oct 20164:30 pmRNSDirector/PDMR Shareholding
31st Oct 20164:30 pmRNSTotal Voting Rights
28th Oct 20164:15 pmRNSDirector/PDMR Shareholding
27th Oct 20164:00 pmRNSDirector/PDMR Shareholding
25th Oct 20165:45 pmRNSHolding(s) in Company
25th Oct 20168:07 amRNSAdmission of Nil Paid Rights
24th Oct 201610:15 amRNSEGM Results Announcement
19th Oct 20164:30 pmRNSHolding(s) in Company
17th Oct 20165:30 pmRNSRegulatory Consent - AXA Business Acquisition
14th Oct 20164:30 pmRNSDirector/PDMR Shareholding
12th Oct 20164:00 pmRNSBlock listing Interim Review
7th Oct 20164:02 pmRNSDirector/PDMR Shareholding
5th Oct 201610:00 amRNSHolding(s) in Company
4th Oct 20165:41 pmRNSCircular and Prospectus Publication
4th Oct 201610:00 amRNSHolding(s) in Company
30th Sep 20164:05 pmRNSTotal Voting Rights
28th Sep 20168:00 amRNSProposed Acquisition of Abbey Life

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.